Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Anemia

Free Subscription Articles published in Leukemia Retrieve available abstracts of 29 articles: HTML format

Single Articles

November 2023
1. LIU Y, Karlsson S
   Perspectives of current understanding and therapeutics of Diamond-Blackan anemia.
   Leukemia. 2023 Nov 16. doi: 10.1038/s41375-023-02082.
   PubMed     Abstract available
   
   
   
2. BAUER K, Machherndl-Spandl S, Kazianka L, Sadovnik I, et al
   CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
   Leukemia. 2023;37:2250-2260.
   PubMed     Abstract available
   
   
   October 2023
3. FATTIZZO B, Gurnari C, Cassanello G, Bortolotti M, et al
   Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
   Leukemia. 2023 Oct 4. doi: 10.1038/s41375-023-02047.
   PubMed     Abstract available
   
   
   August 2023
4. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
   Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
   Leukemia. 2023 Aug 25. doi: 10.1038/s41375-023-02011.
   PubMed    
   
   
   June 2023
5. MARION W, Koppe T, Chen CC, Wang D, et al
   RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
   Leukemia. 2023 Jun 30. doi: 10.1038/s41375-023-01945.
   PubMed     Abstract available
   
   
   
6. GALE RP, Hinterberger W, Young NS, Gennery AR, et al
   What causes aplastic anaemia?
   Leukemia. 2023;37:1191-1193.
   PubMed    
   
   
   May 2023
7. NIKITIN E, Kislova M, Morozov D, Belyakova V, et al
   Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
   Leukemia. 2023 May 18. doi: 10.1038/s41375-023-01891.
   PubMed     Abstract available
   
   
   February 2023
8. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
   Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
   Leukemia. 2023;37:500-502.
   PubMed    
   
   
   October 2022
9. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
   Molecular landscape of immune pressure and escape in aplastic anemia.
   Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
   PubMed     Abstract available
   
   
   September 2022
10. MESA R, Harrison C, Oh ST, Gerds AT, et al
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
    Leukemia. 2022;36:2261-2268.
    PubMed     Abstract available
    
    
    August 2022
11. KELKKA T, Tyster M, Lundgren S, Feng X, et al
    Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
    Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
    PubMed     Abstract available
    
    
    July 2022
12. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    PubMed     Abstract available
    
    
    May 2022
13. HUANG Y, Chen M, Yang C, Ruan J, et al
    Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
    Leukemia. 2022;36:1351-1360.
    PubMed     Abstract available
    
    
    
14. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
    Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Leukemia. 2022;36:1432-1435.
    PubMed    
    
    
    April 2022
15. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
    PubMed     Abstract available
    
    
    
16. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
    Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
    Leukemia. 2022;36:1189-1192.
    PubMed    
    
    
    January 2022
17. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    PubMed    
    
    
    October 2021
18. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    PubMed     Abstract available
    
    
    September 2021
19. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    PubMed    
    
    
    August 2021
20. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    PubMed    
    
    
    
21. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    PubMed    
    
    
    June 2021
22. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    PubMed    
    
    
    May 2021
23. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    PubMed     Abstract available
    
    
    April 2021
24. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    PubMed     Abstract available
    
    
    
25. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    PubMed     Abstract available
    
    
    March 2021
26. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    PubMed     Abstract available
    
    
    
27. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    PubMed     Abstract available
    
    
    
28. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    PubMed     Abstract available
    
    
    November 2020
29. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.